Life Science M&A Transactions

Generation Bio is a biotechnology company a new generation of re-dosable, long-lasting gene therapy on a scale to potentially benefit more families living with a broader range of diseases around the world. Generation Bio was founded in 2016 and is based in Cambridge, Massachusetts.

XOMA Royalty
Company
Life Science
Emeryville, California
www.xoma.com

Cofactor Genomics is a biotechnology company that develops a platform based on RNA that enables early detection and diagnosis of a disease. Cofactor Genomics is based in St. Louis, Missouri.

LabCorp
Company
Test/Measurement Equipment
Burlington, North Carolina
www.labcorp.com

Tissue Testing Technologies is a biotechnology company specialising in biopreservation .T3's advanced proprietary technologies and services preserve living cells and tissues for clinical and research applications, ensuring the quality and impact of life-saving therapies. Tissue Testing Technologies was founded in 2014 and is based in North Charleston, South Carolina.

LifeNet Health
Company
Healthcare Services
Virginia Beach, Virginia
www.lifenethealth.org

Piedmont Research Partners is a clinical research site specializing in Phase II–IV clinical trials across multiple therapeutic areas, including Cardiology, Endocrinology, Rheumatology, GI and Immunology. Piedmont Research Partners is based in Indian Land, South Carolina.

ObjectiveHealth
Company
Healthcare Services
Franklin, Tennessee
www.objective.health

START Carolinas is a clinical research organisation focused on conducting urologic clinical trials and research studies, particularly in areas such as prostate, bladder, and renal diseases. START Carolinas was founded in 1998 and is based in Myrtle Beach, South Carolina.

START
Company
Life Science
San Antonio, Texas
www.startresearch.com
Advisor: Reed Smith

Arthrosi Therapeutics Is focused on developing pozdeutinurad, a potentially best-in-class, highly potent and selective next generation URAT1 inhibitor to reduce serum urate levels, flares and tophi in patients with progressive gout. Arthrosi Therapeutics is based in San Diego, California.

Sobieski & Bradley, Inc.
Company
Insurance
South Jordan, Utah
www.sbins.com
Advisors: McDermott Will & Emery , Barclays Investment Bank

SafePath develops, manufactures, and markets immunoassay diagnostic products and contract manufacturing services for veterinary health and related markets. SafePath was founded in 1995 and is headquartered in Carlsbad, California.

KVP
Company
Business Services
McKinney, Texas
www.kvpvet.com

Velocity Bioworks will offer integrated contract development and manufacturing services at its purpose-built, state-of-the-art facility in San Antonio. Velocity Bioworks focuses on rapidly advancing biologic programs to the clinic and will offer a broad array of analytical testing, process development, and manufacturing services. Velocity Bioworks is based in Durham, North Carolina.

Tivic
Company
Electronics
Fremont, California
www.tivichealth.com

Scorpius Holdings
Company
Life Science
Morrisville, North Carolina
www.scorpiusbiologics.com

Veralox Therapeutics's VLX-1005 includes all the VLX-1005 and related 12-lipoxygenase (12-LOX) assets. VLX-1005 is a novel, potent, selective small-molecule inhibitor of 12-LOX, a key pathway driving immune platelet-mediated inflammation and a contributor to the pathogenesis of HIT. Veralox Therapeutics's VLX-1005 is based in Frederick, Maryland.

Cadrenal Therapeutics
Company
Life Science
Ponte Vedra, Florida
www.cadrenal.com

Veralox Therapeutics
Company
Life Science
Frederick, Maryland
www.veralox.com

Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. Applied Therapeutics is based in New York, New York.

Cycle Pharmaceuticals
Company
Life Science
Cambridge, United Kingdom
www.cyclepharma.com

MyOme is a clinical whole-genome analysis platform company that provides genomic sequencing and analysis services to help individuals and healthcare providers understand genetic risk factors for inherited diseases, guide personalised health decisions, and support diagnostic evaluation. MyOme was founded in 2017 and is headquartered in Menlo Park, California.

Illumina
Company
Life Science
San Diego, California
www.illumina.com

Pharmathen's Ophthalmology Business is primarily a glaucoma‑focused pharmaceutical portfolio. Pharmathen's Ophthalmology Business is based in Amstelveen, Netherlands.

NTC
Company
Life Science
Milan, Italy
www.ntcpharma.com
Advisors: Deloitte Legal - Laga , KPMG Corporate Finance

Pharmathen
Company
Life Science
Amstelveen, Netherlands
www.pharmathen.com

InduPro is a biotechnology company defining and harnessing inherent and induced proximity biology to unlock next-generation therapeutics in cancer and autoimmune diseases. The Company develops therapeutics against novel, tumor-selective targets and co-target pairs using bispecific antibodies including antibody drug conjugates (ADCs) and T cell engagers (TCEs), fueling a robust pipeline of first- and best-in-class programs. InduPro is based in Seattle, Washington.

Sanofi
Company
Life Science
Paris, France
www.sanofi.com

Staccato OBT is a breath-activated drug-delivery platform originally developed to deliver aerosolized medicines rapidly, non-invasively, with onset times similar to intravenous administration. The technology has been applied to therapeutic programs such as loxapine for acute agitation and is being developed for other central-nervous-system indications in collaboration with biopharmaceutical partners.

Lee’s Pharmaceutical
Company
Life Science
Hong Kong, China
www.leespharm.com

Alexza Pharmaceuticals, Inc.
Company
Life Science
Mountain View, California
www.alexza.com

Bluejay Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing potentially life-changing therapeutics for serious viral and liver diseases. The company is currently investigating brelovitug for the treatment of chronic hepatitis delta virus (HDV) and chronic hepatitis B (CHB) viral infections. Additionally, Bluejay is advancing several innovative programs with the goal of developing a combination regimen to achieve a functional cure for chronic hepatitis B, including a proprietary TLR9 agonist (cavrotolimod) and a liver-targeted HBV transcript inhibitor (BJT-628). Bluejay Therapeutics is based in Redwood City, California.

Mirum
Company
Life Science
Foster City, California
www.mirumpharma.com
Advisors: Cooley , Morgan Stanley , Cantor Fitzgerald

Total Infusion Care is a home-infusion speciality pharmacy that provides intravenous therapy and related services for patients transitioning from hospital care to home care. Total Infusion Care was founded in 2012 and is based in Henderson, Nevada.

BioMatrix Specialty Pharmacy
Company
Life Science
Plantation, Florida
www.biomatrixsprx.com